A comparative study of insulin lispro and human regular insulin in patients with type 2 diabetes mellitus and secondary failure of oral hypoglycemic agents

December 2001
Clinical & Investigative Medicine;Dec2001, Vol. 24 Issue 6, p292
Academic Journal
Presents information on a study which compared the effects of insulin lispro and human regular insulin on glycemic control, daily blood glucose profiles and rates of hypoglycemia in patients with type 2 diabetes mellitus after failure to respond to sulfonylurea drugs. Research design and methods; Results; Discussion and conclusions.


Related Articles

  • Exogenous insulin increased risk for complications, mortality in type 2 diabetes.  // Endocrine Today;Mar2013, Vol. 11 Issue 3, p24 

    The article reports on a study which found that exogenous insulin therapy is linked to an increased risk for diabetes-related complications, cancer and all-cause mortality among patients with type 2 diabetes.

  • Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin. Rosenstock, Julio; Schwartz, Sherwyn L.; Clark Jr., Charles M.; Park, Glen D.; Donley, David W.; Edwards, Mike B.; Rosenstock, J; Schwartz, S L; Clark, C M Jr; Park, G D; Donley, D W; Edwards, M B // Diabetes Care;Apr2001, Vol. 24 Issue 4, p631 

    Objective: To determine the safety and efficacy of the long-acting analog insulin glargine compared with NPH insulin in patients with type 2 diabetes who were previously treated with insulin alone.Research Design and Methods: A total of 518 subjects with type 2 diabetes...

  • Insulin.  // Reactions Weekly;8/7/2010, Issue 1313, p27 

    The article describes the case of a 48-year-old man who experienced two cutaneous amyloid tumors while being treated with recombinant human insulin for type 2 diabetes, referencing a study published in the March 2010 issue of the "Netherlands Journal of Medicine."

  • Mix It Up.  // Diabetes Forecast;Jan/Feb2016, Vol. 69 Issue 1, p15 

    The article offers suggestions for taking NPH ("N") intermediate-acting insulin and mentions similar results among type 2 diabetes patients after using NPH vials.

  • Insulin detemir.  // Reactions Weekly;5/15/2010, Issue 1301, p30 

    The article describes the case of a man who developed allergic skin reactions while receiving treatment with insulin detemir for type 2 diabetes mellitus.

  • Erratum.  // Diabetes Care;Dec2013, Vol. 36 Issue 12, p4172 

    A correction to the article "Combining Incretin-Based Therapies With Insulin: Realizing the Potential in Type 2 Diabetes" that was published in the journal in 2013 is presented.

  • Insulin plus a sulfonylurea agent for treating type 2 diabetes. Peters, Anne L.; Peters, A L; Davidson, M B // Annals of Internal Medicine;7/1/91, Vol. 115 Issue 1, p45 

    Purpose: To review the recent literature on the efficacy of combined insulin and sulfonylurea therapy in patients with type 2 diabetes.Data Sources: Pertinent articles were obtained through an English-language MEDLINE search from 1979 to 1990 and from the references of...

  • Statins delay initiation of insulin in type 2 diabetes.  // Geriatrics;Aug2002, Vol. 57 Issue 8, p35 

    Suggests that use of statins may delay the initiation of insulin therapy in patients with type 2 diabetes, according to a study presented at the annual meeting of the American Diabetes Association in June 2002 in San Francisco, California. Mechanism of action; Methodology; Interpretation of...

  • DURABLE trial: Twice-daily insulin lispro mix improved glycemic control. Foster, Melissa; Kalvaitis, Katie; McKnight, Whitney // Endocrine Today;Apr2011, Vol. 9 Issue 4, p48 

    The article discusses research being done on the role of earlier insulin initiation in improving glycemic control in patients with type 2 diabetes, referencing a study by J. B. Buse et al, published in a 2011 issue of "Diabetes Care."


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics